Point-of-Care Glucose Testing Market by Product (Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System), Mode of Purchase (OTC Testing Product, Prescription-Based Testing Product), End-User - Global Forecast 2024-2030

Point-of-Care Glucose Testing Market by Product (Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System), Mode of Purchase (OTC Testing Product, Prescription-Based Testing Product), End-User - Global Forecast 2024-2030

The Point-of-Care Glucose Testing Market size was estimated at USD 6.70 billion in 2023 and expected to reach USD 7.20 billion in 2024, at a CAGR 7.54% to reach USD 11.15 billion by 2030.

Global Point-of-Care Glucose Testing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Point-of-Care Glucose Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Point-of-Care Glucose Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Point-of-Care Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc. by Inverness Medical Innovations, Inc., Bio-Rad Laboratories, Danaher Corporation, EKF Diagnostics by IBL PLC, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, Prodigy Diabetes Care, LLC., Siemens Healthineers AG, and Sinocare.

Market Segmentation & Coverage

This research report categorizes the Point-of-Care Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Accu Check Aviva Meter
Accu-Chek Inform II
Bayer Contour Blood Glucose Monitoring System
Freestyle Lite
i-STAT
Onetouch Verio Flex
StatStrip
True Metrix
Mode of Purchase
OTC Testing Product
Prescription-Based Testing Product
End-User
Home Care Settings
Hospitals & Critical Care Centers
Outpatient & Ambulatory Care Facilities
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Point-of-Care Glucose Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Point-of-Care Glucose Testing Market?
3. What are the technology trends and regulatory frameworks in the Point-of-Care Glucose Testing Market?
4. What is the market share of the leading vendors in the Point-of-Care Glucose Testing Market?
5. Which modes and strategic moves are suitable for entering the Point-of-Care Glucose Testing Market?

Note: PDF & Excel + Online Access - 1 Year